JP2021517139A5 - - Google Patents
Info
- Publication number
- JP2021517139A5 JP2021517139A5 JP2020547139A JP2020547139A JP2021517139A5 JP 2021517139 A5 JP2021517139 A5 JP 2021517139A5 JP 2020547139 A JP2020547139 A JP 2020547139A JP 2020547139 A JP2020547139 A JP 2020547139A JP 2021517139 A5 JP2021517139 A5 JP 2021517139A5
- Authority
- JP
- Japan
- Prior art keywords
- ophthalmic composition
- inflammation
- allergic conjunctivitis
- composition according
- compound
- Prior art date
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862641094P | 2018-03-09 | 2018-03-09 | |
| US62/641,094 | 2018-03-09 | ||
| US201862663999P | 2018-04-27 | 2018-04-27 | |
| US62/663,999 | 2018-04-27 | ||
| PCT/US2019/021402 WO2019173744A1 (en) | 2018-03-09 | 2019-03-08 | Methods of use and pharmaceutical compositions of a selective syk inhibitor |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2021517139A JP2021517139A (ja) | 2021-07-15 |
| JP2021517139A5 true JP2021517139A5 (https=) | 2022-03-10 |
| JPWO2019173744A5 JPWO2019173744A5 (https=) | 2022-03-10 |
| JP7417531B2 JP7417531B2 (ja) | 2024-01-18 |
Family
ID=65818744
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020547139A Active JP7417531B2 (ja) | 2018-03-09 | 2019-03-08 | 選択的ｓｙｋ阻害剤の使用方法および医薬組成物 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20210052582A1 (https=) |
| EP (1) | EP3761986A1 (https=) |
| JP (1) | JP7417531B2 (https=) |
| KR (1) | KR20210018193A (https=) |
| CN (2) | CN112243375A (https=) |
| AU (1) | AU2019230220B2 (https=) |
| BR (1) | BR112020018377A2 (https=) |
| CA (1) | CA3093371A1 (https=) |
| IL (1) | IL277093A (https=) |
| MX (1) | MX2020009396A (https=) |
| PH (1) | PH12020551418A1 (https=) |
| SG (1) | SG11202008765UA (https=) |
| TW (1) | TWI805705B (https=) |
| WO (1) | WO2019173744A1 (https=) |
| ZA (1) | ZA202005459B (https=) |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007056457A2 (en) * | 2005-11-09 | 2007-05-18 | Combinatorx, Incorporated | Methods, compositions, and kits for the treatment of medical conditions |
| KR101454674B1 (ko) | 2006-03-17 | 2014-10-27 | 존슨 앤드 존슨 비젼 케어, 인코포레이티드 | 산화에 불안정한 성분을 포함하는 안정화된 안과용 조성물 |
| MX2010011463A (es) * | 2008-04-16 | 2011-06-03 | Portola Pharm Inc | 2,6-diamino-pirimidin-5-il-carboxamidas como inhibidores de syk o jak quinasas. |
| SG2014015085A (en) * | 2008-04-16 | 2014-06-27 | Portola Pharm Inc | 2,6-diamino-pyrimidin-5-yl-carboxamides as syk or jak kinases inhibitors |
| KR20140103168A (ko) * | 2011-12-16 | 2014-08-25 | 알러간, 인코포레이티드 | 폴리비닐 카프라락탐-폴리비닐 아세테이트-폴리에틸렌 글리콜 그라프트 코폴리머를 포함하는 안과 조성물 |
| AR090650A1 (es) * | 2012-04-12 | 2014-11-26 | Alcon Res Ltd | Tratamiento para respuestas inflamatorias inducidas por microbios en el ojo |
| EP2897950A1 (en) * | 2012-09-18 | 2015-07-29 | Ziarco Pharma Ltd | 2-(2-aminocyclohexyl)amino-pyrimidine-5-carboxamides as spleen tyrosine kinasei(syk) inhibitors |
-
2019
- 2019-03-08 CN CN201980017916.9A patent/CN112243375A/zh active Pending
- 2019-03-08 TW TW108107933A patent/TWI805705B/zh not_active IP Right Cessation
- 2019-03-08 AU AU2019230220A patent/AU2019230220B2/en active Active
- 2019-03-08 JP JP2020547139A patent/JP7417531B2/ja active Active
- 2019-03-08 EP EP19712475.3A patent/EP3761986A1/en active Pending
- 2019-03-08 KR KR1020207028762A patent/KR20210018193A/ko active Pending
- 2019-03-08 CA CA3093371A patent/CA3093371A1/en active Pending
- 2019-03-08 US US16/979,075 patent/US20210052582A1/en not_active Abandoned
- 2019-03-08 BR BR112020018377-6A patent/BR112020018377A2/pt not_active Application Discontinuation
- 2019-03-08 SG SG11202008765UA patent/SG11202008765UA/en unknown
- 2019-03-08 WO PCT/US2019/021402 patent/WO2019173744A1/en not_active Ceased
- 2019-03-08 CN CN202411182880.9A patent/CN119235862A/zh active Pending
- 2019-03-08 MX MX2020009396A patent/MX2020009396A/es unknown
-
2020
- 2020-09-01 IL IL277093A patent/IL277093A/en unknown
- 2020-09-01 ZA ZA2020/05459A patent/ZA202005459B/en unknown
- 2020-09-09 PH PH12020551418A patent/PH12020551418A1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2019232153B2 (en) | Ophthalmic formulation | |
| DK2614838T3 (en) | Diquafosol and hyaluronic acid or salts thereof for the treatment of dry eyes | |
| JP2019534867A5 (https=) | ||
| US20130190278A1 (en) | Compounds for the Treatment/Prevention of Ocular Inflammatory Diseases | |
| RU2632107C2 (ru) | Пероральная фармацевтическая композиция для профилактики или лечения синдрома "сухого глаза", содержащая ребамипид или его предшественник | |
| JP2011527339A5 (https=) | ||
| KR101778004B1 (ko) | 이마티닙을 유효성분으로 포함하는 안구 건조 질환 예방 및 치료용 약학 조성물 | |
| JP2005145961A (ja) | 角結膜障害の治療剤 | |
| CN102105167A (zh) | 轴性近视的预防或治疗剂 | |
| JP6267003B2 (ja) | ジクアホソルまたはその塩およびレバミピドまたはその塩を組み合わせたことを特徴とする涙液分泌促進剤 | |
| JP7038437B2 (ja) | 眼障害及び皮膚疾患の処置のための化合物、組成物、及び方法 | |
| JP2021517139A5 (https=) | ||
| WO2019024433A1 (zh) | 氨基金刚烷胺单硝酸酯类化合物眼用组合物及其制剂和应用 | |
| RU2019118904A (ru) | Распределение в глазу и фармакокинетика композиций лифитеграста | |
| WO2018056268A1 (ja) | 炎症性眼疾患の治療及び／又は予防剤 | |
| FI4329725T3 (fi) | Isosyklosporiini a silmäsairauksien paikalliseen hoitoon | |
| US20090082455A1 (en) | Therapeutic agent for ophthalmic disease | |
| JPWO2019173744A5 (https=) | ||
| JP7417531B2 (ja) | 選択的ｓｙｋ阻害剤の使用方法および医薬組成物 | |
| US20180221417A1 (en) | Treatment of dry eye using amnion released factors | |
| JP4778515B2 (ja) | 角膜疾患治療剤 | |
| JPWO2020165838A5 (https=) | ||
| WO2026027718A1 (en) | Cxcl8 inhibitors for use in the treatment of ocular graft-versus-host disease | |
| WO2022259133A1 (en) | Trpa1 channel antagonist compound for use in degenerative retinal diseases | |
| WO2007066678A1 (ja) | 角結膜障害治療剤 |